Validated Microwell-Based Spectrofluorimetric Method for Quantification of Ravidasvir (New Anti-Chronic Hepatitis C Virus-GT4) in Rat Plasma and Its Application to Pharmacokinetic Study

BACKGROUND: Ravidasvir (RAV) has been regarded as a potent new NS5A inhibitor with a magnificent safety and tolerability in the management of genotype 4 hepatitis C virus (HCV) patients. Suitable analytical techniques are needed for the measurement of RAV in different biological matrices. METHODS: W...

Descripción completa

Detalles Bibliográficos
Autores principales: Hefnawy, Mohamed, Al-Shehri, Mona, Al-Rashood, Sara, Hammad, Sherif, Alanazi, Mohammed, Alsaif, Nawaf, Mohammed, Mostafa, Obaidullah, Ahmad, El-Gendy, Manal
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2020
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7585829/
https://www.ncbi.nlm.nih.gov/pubmed/33116422
http://dx.doi.org/10.2147/DDDT.S237949

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7585829/
https://www.ncbi.nlm.nih.gov/pubmed/33116422
http://dx.doi.org/10.2147/DDDT.S237949

Ejemplares similares